Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RXDX: Morn. gapper, though --- did ya grab some in the Pre-Market, King EZ??
$RXDX: BOOOOOOOMMMMMMMMMMMMMM
Ohhhhhhhhhh yaaaaaaaaaaaaaa............. Just tapped $133 from $36 yesterdays close.
HELLO !!!!!!!
$RXDX Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb
https://www.prometheusbiosciences.com/
GO $RXDX
ORAL PRESENTATION NEXT WEDNESDAY THE 18TH WITH UPDATED DATA
JPMORGAN UPS THEIR PT TO $20 TODAY
BAKER BROTHERS HAVE INCRESED THEIR HOLDINGS BY 57% DURING THE SECOND Q
MULTIPLE NDA TO BE FILED IN 2018
88% OF THE OS ARE OWNED BY INSITUTIONAL INVESTORS
2018 IS GEARING UP TO BE A GREAT YEAR FOR SHAREHOLDERS AND ESPECIALLY FOR THOSE BRAVE PATIENTS THAT ARE BEING TREATED IN THEIR MULTIPLE TRIALS
Today's Webcast link
http://wsw.com/webcast/ladenburg3/rxdx/index.aspx
I meant to say October. .Lung Cancer Conference in Japan..could this have a similiar run like LOXO had?
88% Institutional Ownership with more Data coming this December.
Nice bounce today from way oversold condition... I continue to add and think this stock will be a big winner within a year or so.
Interesting indeed!! I own well over 30k shares and have long felt this was too good to be true with the known results thus far. It's gratifying to be right once in a while lol. I figure it's worth at least twice the current market cap on a buyout situation, maybe three times. Let's see what happens!
Interesting news today. Even more curious is that a poster on the Stocktwits RXDX board (goop) called this ten days ago. He stated on 3/13 that he works in biotech, and that colleagues were saying Ignyta is in discussions with several potential suitors.
I don't actually know anything about this company. Just happened to notice the news when it popped up on my Think or Swim feed. Very little chatter here or on ST. Nevertheless, it seems as though there may be more in the works here vs. the more heavily discussed stocks where everyone is constantly screaming "buyout!"
Good to see the new 52 week high today, even if the market sold off afterwards. The stock is getting more expensive...
Biotech Indexes looked very healthy today. $10's any time now. This stock will be $25-30 by year end IMO.
Doesn't look like this stock is going to wait for me to get a bargain so I bought a third more today just to make sure and keep it interesting.
There has been chatter on SA of RXDX skipping a P3 and being approved from there p2 results in 2018 or 2019. Thoughts? If so,,that would obviously me huge and likely send this stock into the $20's with no problem. Another thing is that they look like an attractive buy out target to me...??
Excellent timing on being bullish, it certainly looks up from here. I would think that over time it would certainly reach those proven top levels where it has been before. Thanks for the heads up and good luck on the adding on dips, this is a quality chart for longs now!
I suppose someone should post a link to Ignyta's updated date
https://finance.yahoo.com/news/ignytas-updated-phase-1-data-120000716.html
Hi Ya'll. Been watching this for a year.. I'm in now. Amazed at how low it went and i'm not in it anywhere near the bottom but I think it has great potential. I will probably add on dips. Most recent news was phenomenal
Waiting for news... Almost anything positive sends this to the teens.
Hoping for a breakout here
I love this stock. It's 9% of my portfolio after adding more today. I'm guessing that I'll be having to trim it in a month.
This thing price targetsshould start to move soon. Lot's of coverage with price targets at $15 and up.
Either there is going to be a lot of egg on some faces or this thing gets going following the summer slumber.
Loading up on RXDX based on calculated value
https://biotechinvesting.info/2016/08/12/portfolio-evaluation/
Feels like some late summer buying pre-fall run up. Moved it off the lows back to $6... Teens soon.
Sold RXDX @ $5.25. Didn't move on buy rating reiteration by Cantor Fitzgerald despite LABU and market being up today.
RXDX
Bought RXDX on Friday @ $5.20.
Consensus Ratings for Ignyta (NASDAQ:RXDX)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating: Buy (Score: 3.00)
Consensus Price Target: $20.60 (299.22% upside)
http://www.marketbeat.com/stocks/NASDAQ/RXDX/
Chart is ugly, but looking for the bottom:
RXDX
Massive inside buy... http://www.conferencecalltranscripts.org/4/summary/?id=2713935
$RXDX recent news/filings
bullish 14.44
hammer candlestick
## source: finance.yahoo.com
Wed, 25 Nov 2015 14:18:00 GMT ~ Technical Insight on Equity Movement - Research on Ignyta, KongZhong, Arbutus Biopharma and Curis
[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 25, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ignyta Inc ...
read full: http://finance.yahoo.com/news/technical-insight-equity-movement-research-141800255.html
*********************************************************
Tue, 24 Nov 2015 13:35:01 GMT ~ Ignyta (RXDX) Looks Good: Stock Jumps 7.1% in Session
read full: http://finance.yahoo.com/news/ignyta-rxdx-looks-good-stock-133501592.html
*********************************************************
Tue, 24 Nov 2015 12:00:00 GMT ~ Ignyta to Present at 27th Annual Piper Jaffray Healthcare Conference
[Business Wire] - Ignyta, Inc. , a precision oncology biotechnology company, announced today that Jonathan Lim, M.D., its Chairman and Chief Executive Officer, will make a presentation at the 27th Annual Piper Jaffray Healthcare Conference on Wednesday, December 2, 2015, at 9:00 a.m.
read full: http://finance.yahoo.com/news/ignyta-present-27th-annual-piper-120000462.html
*********************************************************
Thu, 19 Nov 2015 21:00:00 GMT ~ Moffitt Cancer Center and Ignyta, Inc. Enter into Cancer Research Collaboration for RXDX-106
[Business Wire] - Moffitt Cancer Center and Ignyta, Inc. announced today that they have entered into a research collaboration relating to RXDX-106, Ignyta’s small molecule, pseudo-irreversible inhibitor of TYRO3, AXL, Mer and cMET that is in late stage preclinical development.
read full: http://finance.yahoo.com/news/moffitt-cancer-center-ignyta-inc-210000116.html
*********************************************************
Tue, 17 Nov 2015 18:04:33 GMT ~ IGNYTA, INC. Financials
read full: http://finance.yahoo.com/q/is?s=rxdx
*********************************************************
$RXDX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RXDX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RXDX/company-info
Ticker: $RXDX
OTC Market Place: Not Available
CIK code: 0001557421
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
Incorporated In: DE, USA
Business Description: Ignyta, Inc. is catalyzing personalized medicine with \"Rx/Dx\" solutions for cancer.Our goal is to discover and develop revolutionary new drugs that target activated genes in cancer cells for the customized treatment of cancer patients. We achieve this goal by leveraging our proprietary cancer genomic and epigenomic knowledge bases to discover novel targets and deliver the next generation of targeted therapeutics accompanied by highly informative biomarkers for patient selection, treatment, and monitoring.Less >>
$RXDX share structure
## source: otcmarkets.com
Market Value: $417,341,658 a/o Nov 24, 2015
Shares Outstanding: 29,619,706 a/o Oct 30, 2015
Float: 7,336 a/o Dec 19, 2013
Authorized Shares: 100,000,000 a/o Dec 19, 2013
Par Value: Not Available
$RXDX extra dd links
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RXDX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RXDX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RXDX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/news - http://finance.yahoo.com/q/h?s=RXDX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RXDX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RXDX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RXDX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Ignyta%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Ignyta%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Ignyta%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.ignyta.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.ignyta.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.ignyta.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RXDX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001557421&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RXDX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RXDX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RXDX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RXDX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RXDX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RXDX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RXDX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RXDX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RXDX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RXDX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RXDX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RXDX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RXDX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RXDX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RXDX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RXDX
$RXDX DD Notes ~ http://www.ddnotesmaker.com/RXDX
$RXDX recent news/filings
bullish
bull flag breakout
crossing moving average
bullish engulfing candlestick
## source: finance.yahoo.com
Wed, 02 Sep 2015 11:01:50 GMT ~ IGNYTA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150902/rxdx8-k.html
*********************************************************
Wed, 02 Sep 2015 11:00:00 GMT ~ Ignyta Appoints Valerie Harding as Senior Vice President, Chemistry, Manufacturing, and Controls
[Business Wire] - Ignyta, Inc. , a precision oncology biotechnology company, announced today that Valerie Harding, Ph.D., has been appointed to the newly-created role of Senior Vice President, Chemistry, Manufacturing, and Controls.
read full: http://finance.yahoo.com/news/ignyta-appoints-valerie-harding-senior-110000334.html
*********************************************************
Tue, 01 Sep 2015 20:00:00 GMT ~ Ignyta Announces Entrectinib Clinical Case Report Presentation at the 2015 World Conference on Lung Cancer
[Business Wire] - Ignyta, Inc. , a precision oncology biotechnology company, today announced that an abstract relating to entrectinib, the company’s proprietary oral tyrosine kinase inhibitor targeting solid tumors that harbor activating alterations to TrkA, TrkB, TrkC, ROS1 or ALK, has been selected for a mini-oral presentation at the 16th World Conference on Lung Cancer on September 9, 2015 in Denver, Colorado.
read full: http://finance.yahoo.com/news/ignyta-announces-entrectinib-clinical-case-200000106.html
*********************************************************
Fri, 21 Aug 2015 17:04:13 GMT ~ IGNYTA, INC. Financials
read full: http://finance.yahoo.com/q/is?s=rxdx
*********************************************************
Thu, 20 Aug 2015 11:00:00 GMT ~ Ignyta Reports Granting of Inducement Awards
[Business Wire] - Ignyta, Inc. , a precision oncology biotechnology company, announced today that it has issued inducement awards to five new non-executive employees.
read full: http://finance.yahoo.com/news/ignyta-reports-granting-inducement-awards-110000310.html
*********************************************************
$RXDX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RXDX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RXDX/company-info
Ticker: $RXDX
OTC Market Place: Not Available
CIK code: 0001557421
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
Incorporated In: DE, USA
Business Description: Ignyta, Inc. is catalyzing personalized medicine with \"Rx/Dx\" solutions for cancer.Our goal is to discover and develop revolutionary new drugs that target activated genes in cancer cells for the customized treatment of cancer patients. We achieve this goal by leveraging our proprietary cancer genomic and epigenomic knowledge bases to discover novel targets and deliver the next generation of targeted therapeutics accompanied by highly informative biomarkers for patient selection, treatment, and monitoring.Less >>
$RXDX share structure
## source: otcmarkets.com
Market Value: $422,376,517 a/o Sep 03, 2015
Shares Outstanding: 29,598,915 a/o Jul 31, 2015
Float: 7,336 a/o Dec 19, 2013
Authorized Shares: 100,000,000 a/o Dec 19, 2013
Par Value: Not Available
$RXDX extra dd links
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RXDX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RXDX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RXDX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/news - http://finance.yahoo.com/q/h?s=RXDX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RXDX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RXDX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RXDX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Ignyta%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Ignyta%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Ignyta%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.ignyta.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.ignyta.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.ignyta.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RXDX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001557421&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RXDX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RXDX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RXDX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RXDX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RXDX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RXDX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RXDX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RXDX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RXDX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RXDX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RXDX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RXDX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RXDX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RXDX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RXDX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RXDX
$RXDX DD Notes ~ http://www.ddnotesmaker.com/RXDX
Real nice spike here !
Nice ASCO spike.
Now time to short back down to EMA20.
$RXDX recent news/filings
bullish
## source: finance.yahoo.com
Tue, 02 Jun 2015 12:50:17 GMT ~ The 4 Overlooked Winners of ASCO
read full: http://247wallst.com/healthcare-business/2015/06/02/the-4-overlooked-winners-of-asco/
*********************************************************
Mon, 01 Jun 2015 16:39:30 GMT ~ ImmunoGen, Bristol make strides in cancer battle
read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=DEE09A6A-086F-11E5-971E-11C57B18DFE4&siteid=yhoof2
*********************************************************
Mon, 01 Jun 2015 12:34:17 GMT ~ IGNYTA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150601/rxdx8-k.html
*********************************************************
Mon, 01 Jun 2015 11:02:00 GMT ~ 7:02 am Ignyta announces Phase 1 Clinical Trial Data for Entrectinib; 91% response rate in patients meeting expected Phase 2 eligibility criteria
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#rxdx
*********************************************************
Mon, 01 Jun 2015 11:00:00 GMT ~ Ignyta Announces Phase 1 Clinical Trial Data for Entrectinib
[Business Wire] - Ignyta, Inc. , a precision oncology biotechnology company, today announced that interim results from the company’s two Phase 1 clinical trials of entrectinib were presented in poster presentations, including a poster discussion, at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois.
read full: http://finance.yahoo.com/news/ignyta-announces-phase-1-clinical-110000082.html
*********************************************************
$RXDX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RXDX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RXDX/company-info
Ticker: $RXDX
OTC Market Place: Not Available
CIK code: 0001557421
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
Incorporated In: NV, USA
Business Description: Ignyta, Inc. is catalyzing personalized medicine with \"Rx/Dx\" solutions for cancer.Our goal is to discover and develop revolutionary new drugs that target activated genes in cancer cells for the customized treatment of cancer patients. We achieve this goal by leveraging our proprietary cancer genomic and epigenomic knowledge bases to discover novel targets and deliver the next generation of targeted therapeutics accompanied by highly informative biomarkers for patient selection, treatment, and monitoring.Less >>
$RXDX share structure
## source: otcmarkets.com
Market Value: $376,404,143 a/o Jun 01, 2015
Shares Outstanding: 25,262,023 a/o Apr 30, 2015
Float: 7,336 a/o Dec 19, 2013
Authorized Shares: 100,000,000 a/o Dec 19, 2013
Par Value: Not Available
$RXDX extra dd links
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RXDX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RXDX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RXDX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/news - http://finance.yahoo.com/q/h?s=RXDX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RXDX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RXDX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RXDX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Ignyta%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Ignyta%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Ignyta%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.ignyta.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.ignyta.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.ignyta.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RXDX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001557421&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RXDX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RXDX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RXDX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RXDX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RXDX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RXDX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RXDX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RXDX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RXDX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RXDX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RXDX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RXDX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RXDX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RXDX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RXDX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RXDX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RXDX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RXDX
$RXDX DD Notes ~ http://www.ddnotesmaker.com/RXDX
Ignyta, Inc. [$RXDX] due diligence
bullish
$RXDX
DD Notes ~ http://www.ddnotesmaker.com/RXDX
##### recent news/filings ~ source: finance.yahoo.com
Fri, 27 Jun 2014 22:02:27 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Tue, 24 Jun 2014 20:00:00 GMT ~ Ignyta to be Added to Russell Microcap® Index
[Business Wire] - Ignyta, Inc. , an oncology precision medicine biotechnology company, today announced that the company’s shares will be added to the Russell Microcap® Index following Russell Investments’ reconstitution of its comprehensive set of U.S.
read full: http://finance.yahoo.com/news/ignyta-added-russell-microcap-index-200000863.html
*********************************************************
Tue, 03 Jun 2014 10:34:53 GMT ~ Ignyta (RXDX) Jumps: Stock Adds 12.7% in Session
read full: http://finance.yahoo.com/news/ignyta-rxdx-jumps-stock-adds-103453483.html
*********************************************************
Mon, 02 Jun 2014 10:02:23 GMT ~ IGNYTA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/140602/rxdx8-k.html
*********************************************************
Sun, 01 Jun 2014 17:30:18 GMT ~ Ignyta presents interim results from Phase I clinical trial of RXDX-101
read full: http://finance.yahoo.com/news/ignyta-presents-interim-results-phase-173018444.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RXDX/company-info
Ticker: $RXDX
OTC Market Place: Not Available
CIK code: 0001557421
Company name: Ignyta, Inc.
Company website: http://www.ignyta.com
Incorporated In: NV, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001557421&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/RXDX/filings
Latest financials: http://www.otcmarkets.com/stock/RXDX/financials
Latest news: http://www.otcmarkets.com/stock/RXDX/news - http://finance.yahoo.com/q/h?s=RXDX+Headlines
Major holdings: http://data.cnbc.com/quotes/RXDX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=RXDX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/RXDX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=RXDX
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=RXDX&search=search
DTCC: http://search2.dtcc.com/?q=Ignyta%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Ignyta%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Ignyta%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.ignyta.com
Alexa: http://www.alexa.com/siteinfo/http://www.ignyta.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.ignyta.com
Short Sales: http://www.otcmarkets.com/stock/RXDX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/RXDX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/RXDX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=RXDX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=RXDX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=RXDX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=RXDX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=RXDX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=RXDX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=RXDX
Balance Sheet: http://finance.yahoo.com/q/bs?s=RXDX
Cash Flow: http://finance.yahoo.com/q/cf?s=RXDX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/RXDX
Bloomberg: http://www.bloomberg.com/quote/RXDX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=RXDX
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RXDX
Barchart: http://www.barchart.com/quotes/stocks/RXDX
OTC Short Report: http://otcshortreport.com/index.php?index=RXDX
Investopedia: http://www.investopedia.com/markets/stocks/RXDX/?wa=0
http://www.pennystocktweets.com/stocks/profile/RXDX
##### last known share structure ~ source: otcmarkets.com
Market Value: $160,944,213 a/o Jun 27, 2014
Shares Outstanding: 19,579,588 a/o May 01, 2014
Float: 7,336 a/o Dec 19, 2013
Authorized Shares: 100,000,000 a/o Dec 19, 2013
Par Value: Not Available
##### business description ~ source: otcmarkets.com
Ignyta, Inc. is catalyzing personalized medicine with \"Rx/Dx\" solutions for cancer.Our goal is to discover and develop revolutionary new drugs that target activated genes in cancer cells for the customized treatment of cancer patients. We achieve this goal by leveraging our proprietary cancer genomic and epigenomic knowledge bases to discover novel targets and deliver the next generation of targeted therapeutics accompanied by highly informative biomarkers for patient selection, treatment, and monitoring.Less >>
DD Notes ~ http://www.ddnotesmaker.com/RXDX
cube1
Current Major Investors
City Hill Venture Partners 17%
1798 Fundamental Strategies Master Fund 3.4%
Boxer Capital 2.78%
Baker Brothers Life Sciences 2.64%
Armistice Capital Master Fund 2.55%
Foresite Capital Fund 2.55%
Sabby Healthcare Volatility Master Fund 2.8%
Visium Balanced Master Fund 4.26%
venBio Select Fund 2.13%
Merlin Nexus IV 2.4%
Three Arch Opportunity Fund 1.28%
Current holdings of management
Total shares 3.5M or 18%
Outstanding common shares; 13.9M
Prior Class A and Class B shares have all been converted to common.
Cash $41.787
Relevant History
Partnerships, Licensing, Mergers, ...
In May 2013, Ignyta Operating acquired Actagene Oncology, Inc. (Actagene) by way of Actagene’s merger with and into Ignyta Operating on May 20, 2013. All consideration paid by Ignyta Operating in connection with its acquisition of Actagene was paid with shares of its common stock, totaling an aggregate of 1,583,336 shares.
On November 6, 2013, pursuant to the terms of a license agreement between Ignyta Operating and Nerviano Medical Sciences S.r.l (NMS), Ignyta issued to NMS a warrant to acquire up to 16,667 shares of its common stock at an exercise price of $6.00 per share.
Relevant History
Investor owned stock
On November 6, 2013, Ignyta issued 7,740,142 shares of its common stock to 52 accredited investors pursuant to the terms of a securities purchase agreement entered into with such investors in a private placement offering (the Initial Private Placement). Ladenburg Thalmann & Co. Inc. served as the placement agent in the Initial Private Placement. On November 29, 2013, Ignyta issued 1,270,096 shares of its common stock to 195 accredited investors pursuant to the terms of a securities purchase agreement entered into with such investors in a private placement offering (the Subsequent Private Placement, and together with the Initial Private Placement, the Private Placements). National Securities Corporation served as the placement agent in the Subsequent Private Placement. All of the shares of Ignyta’s common stock issued in the Private Placements were sold at a purchase price per share of $6.00, for aggregate gross proceeds to Ignyta of approximately $54.1 million.
In June 2012, Ignyta Operating issued and sold to six investors an aggregate of 700,000 shares of its series B preferred stock at a purchase price per share of $3.00 and for an aggregate purchase price of $2,100,000. In December 2012, Ignyta Operating issued and sold to fifteen investors, including three investors from the June 2012 sales, an aggregate of 1,135,000 shares of its series B preferred stock at a purchase price per share of $3.00 and for an aggregate purchase price of $3,405,000.
In June 2012, upon entry into and as a condition of a loan and security agreement with Silicon Valley Bank (SVB), Ignyta Operating issued to SVB a warrant to acquire up to 8,334 shares of its series B preferred stock at an exercise price of $3.00 per share.
Relevant History
Employee owned stock
Upon its inception in August 2011, Ignyta Operating issued to four individuals that founded the company an aggregate of 666,668 shares of its common stock at a purchase price per share of $0.003 and for an aggregate purchase price of $2,000. ... ; and the securities were issued as restricted securities.
In October 2011, Ignyta Operating issued and sold to one investor 416,667 shares of its series A preferred stock at a purchase price per share of $0.60 and for an aggregate purchase price of $250,000. In March 2012, Ignyta Operating issued and sold to the same investor an additional 416,667 share of its series A preferred stock at a purchase price per share of $0.60 and for an aggregate purchase price of $250,000.
In June 2012, Ignyta Operating issued and sold to six investors an aggregate of 700,000 shares of its series B preferred stock at a purchase price per share of $3.00 and for an aggregate purchase price of $2,100,000. In December 2012, Ignyta Operating issued and sold to fifteen investors, including three investors from the June 2012 sales, an aggregate of 1,135,000 shares of its series B preferred stock at a purchase price per share of $3.00 and for an aggregate purchase price of $3,405,000.
In August 2012, Ignyta issued 160,000 shares of its common stock to Betty Sytner, one of its officers and sole director.
Upon the closing of the October 31, 2013 merger in which Ignyta Operating became our wholly owned subsidiary, Ignyta issued 4,916,469 shares of its common stock to 27 former stockholders of Ignyta Operating in exchange for all of the outstanding shares of Ignyta Operating’s capital stock. As of the date hereof, 400,000 of such shares have been repurchased by Ignyta and 4,516,469 of such shares remain outstanding.
Since its inception in August 2011, Ignyta Operating granted, under the Ignyta Plan, options to purchase up to an aggregate of 442,983 shares of its common stock to 31 different employees, consultants or other service providers as compensation for services rendered to Ignyta Operating. An aggregate of 12,290 shares have been issued by Ignyta and Ignyta Operating, collectively, upon the exercise of certain of those options
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
47
|
Created
|
01/04/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |